Sunesis Pharmaceuticals (FRA:RYIS) Days Payable : 0.00 (As of Dec. 2020)

View and export this data going back to 2007. Start your Free Trial

What is Sunesis Pharmaceuticals Days Payable?

Sunesis Pharmaceuticals's average Accounts Payable for the three months ended in Dec. 2020 was €0.26 Mil. Sunesis Pharmaceuticals's Cost of Goods Sold for the three months ended in Dec. 2020 was €0.00 Mil.

The historical rank and industry rank for Sunesis Pharmaceuticals's Days Payable or its related term are showing as below:

FRA:RYIS's Days Payable is not ranked ^*
in the Biotechnology industry.
Industry Median: 150.695
* Ranked among companies with meaningful Days Payable only.

Sunesis Pharmaceuticals's Days Payable stayed the same from Dec. 2019 (0.00) to Dec. 2020 (0.00). stayed the same

Sunesis Pharmaceuticals Days Payable Historical Data

The historical data trend for Sunesis Pharmaceuticals's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sunesis Pharmaceuticals Days Payable Chart

Sunesis Pharmaceuticals Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Days Payable

Get a 7-Day Free Trial

Sunesis Pharmaceuticals Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
Days Payable	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Sunesis Pharmaceuticals's Days Payable

For the Biotechnology subindustry, Sunesis Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sunesis Pharmaceuticals's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sunesis Pharmaceuticals's Days Payable distribution charts can be found below:

* The bar in red indicates where Sunesis Pharmaceuticals's Days Payable falls into.

Sunesis Pharmaceuticals Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Sunesis Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2020 is calculated as

	Days Payable (A: Dec. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2019 )	+	Accounts Payable (A: Dec. 2020 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2020 )	*	Days in Period
=	( (0.712	+	0.394)	/	2 )	/	0	*	365
=	0.553					/	0	*	365
=	N/A

Sunesis Pharmaceuticals's Days Payable for the quarter that ended in Dec. 2020 is calculated as:

	Days Payable (Q: Dec. 2020 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Sep. 2020 )	+	Accounts Payable (Q: Dec. 2020 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2020 )	*	Days in Period
=	( (0.127	+	0.394)	/	2 )	/	0	*	365 / 4
=	0.2605					/	0	*	365 / 4
=	N/A

Sunesis Pharmaceuticals Days Payable Related Terms

Thank you for viewing the detailed overview of Sunesis Pharmaceuticals's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Sunesis Pharmaceuticals (FRA:RYIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sunesis Pharmaceuticals Inc (FRA:RYIS) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

395 Oyster Point Boulevard, Suite 400, South San Francisco, CA, USA, 94080

Website

http://www.sunesis.com

Sunesis Pharmaceuticals Inc is a US-based biopharmaceutical company. It focuses on the development and commercialization of its pipeline of oncology therapeutics for the treatment of solid and hematologic cancers. The product portfolio of the company includes Vosaroxin which is an anticancer quinolone derivative for the treatment of acute myeloid leukemia (AML). The company's other kinase inhibitor pipeline includes TAK-580, SNS-062, and SNS-229. Further, the firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The firm derives substantially the majority of revenue from license and collaboration agreements.

Sunesis Pharmaceuticals (FRA:RYIS) Headlines

No Headlines